# A Pharmacokinetic Study of [14C]-GDC-0810 After Single Oral Administration in Healthy Female Participants

> **NCT02802670** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 7 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [14C]-GDC-0810

## Key facts

- **NCT ID:** NCT02802670
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2016-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02802670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02802670, "A Pharmacokinetic Study of [14C]-GDC-0810 After Single Oral Administration in Healthy Female Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02802670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*